ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
LENZ Therapeutics Inc

LENZ Therapeutics Inc (LENZ)

16.02
-1.47
(-8.40%)
Closed April 21 4:00PM
15.79
-0.23
(-1.44%)
After Hours: 7:59PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
16.02
Bid
15.58
Ask
15.98
Volume
81,559
15.76 Day's Range 17.66
15.09 52 Week Range 24.59
Market Cap
Previous Close
17.49
Open
17.40
Last Trade
20
@
15.99
Last Trade Time
Financial Volume
$ 1,346,322
VWAP
16.5073
Average Volume (3m)
112,990
Shares Outstanding
57,996,000
Dividend Yield
-
PE Ratio
-7.35
Earnings Per Share (EPS)
-2.15
Revenue
-
Net Profit
-124.65M

About LENZ Therapeutics Inc

Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire disease-causing genes with normal genes, or insert ... Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire disease-causing genes with normal genes, or insert new genes into predetermined, safe locations. Its lead product candidate GPH101 is a differentiated approach with the potential to directly correct the mutation that causes sickle cell disease (SCD) and restore normal adult hemoglobin (HgbA) expression. All of the company's long-lived assets are based in the United States. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
LENZ Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker LENZ. The last closing price for LENZ Therapeutics was $17.49. Over the last year, LENZ Therapeutics shares have traded in a share price range of $ 15.09 to $ 24.59.

LENZ Therapeutics currently has 57,996,000 shares outstanding. The market capitalization of LENZ Therapeutics is $915.76 million. LENZ Therapeutics has a price to earnings ratio (PE ratio) of -7.35.

LENZ Latest News

LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials

– LNZ100 selected as lead candidate – Primary endpoint was met with 71% of participants dosed with LNZ100 achieving three-lines or greater improvement at 3 hours – Rapid onset and long duration...

LENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia Trials

 Conference call and webcast on Wednesday, April 3, 2024, at 8:00 a.m. EST LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-5.48-25.48837209321.522.03515.767145019.23560533CS
40.040.25031289111415.9824.5915.0911299020.19060169CS
120.040.25031289111415.9824.5915.0911299020.19060169CS
260.040.25031289111415.9824.5915.0911299020.19060169CS
520.040.25031289111415.9824.5915.0911299020.19060169CS
1560.040.25031289111415.9824.5915.0911299020.19060169CS
2600.040.25031289111415.9824.5915.0911299020.19060169CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWGTop Wealth Group Holding Ltd
$ 3.73
(101.62%)
36.52M
CSLRComplete Solaria Inc
$ 0.465319
(75.59%)
16.64M
SHOTWSafety Shot Inc
$ 0.48
(60.00%)
6.71k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
MNDRMobile health Network Solutions
$ 27.2386
(33.72%)
10.35M
YYAIConnexa Sports Technologies Inc
$ 0.8943
(-57.21%)
13.4M
SBFMSunshine Biopharma Inc
$ 1.77
(-46.69%)
11.9M
GTIGraphjet Technology
$ 6.43
(-33.09%)
95.33k
ISPCiSpecimen Inc
$ 0.2883
(-31.52%)
2.86M
BGLCBioNexus Gene Lab Corporation
$ 0.5998
(-29.32%)
735.88k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
SQQQProShares UltraPro Short QQQ
$ 12.84
(6.38%)
219.91M
AGBAAGBA Group Holding Ltd
$ 1.255
(21.84%)
128.79M
TQQQProShares UltraPro QQQ
$ 49.48
(-6.20%)
125.4M
SINTSiNtx Technologies Inc
$ 0.0414
(3.50%)
109.94M

Discussion

View Full Feed
louieforpar louieforpar 9 minutes ago
Seems Trump didn’t want his hair to get wet. Whatever happened to his “big indoor” venues?

Either he can’t afford it due to his money issues or his crowd sizes don’t warrant it.






https://www.wect.com/2024/04/18/wect-livestream-tru
DJT
thistraderknowsall thistraderknowsall 15 minutes ago
SHIB Altcoin upgrade !!!!! SHIB worth .01 now!! Congrats!

Shibarium, the layer-2 (L2) blockchain of the Shiba Inu [SHIB] ecosystem, announced a major UI upgrade. It’s aimed at improving user experience and broadening options for network interactions.

According to Shibar
TRAPPER JIM TRAPPER JIM 16 minutes ago
Sleeping in my chair with Oreo tonight. He’s sick and just not feeling well at all. He’s been throwing up and just like standing around like he doesn’t know what’s going on . Just staring out into space.
peterus peterus 17 minutes ago
geez man insiders own 4.5%
tell it all .... dilution pos
JAGX
joev2 joev2 18 minutes ago
TA, I see we both read each others boards. My intro to Sint (couldn't even remember at first) was when I saw it crashed sometime in 2016. Somehow, it caught my attention via headline or maybe biggest loser of day. Curious about it, I proceeded cautiously, thinking it was possible (exceptionally rare
SINT
newmedman newmedman 20 minutes ago
that thread is friggin hilarious. LOL poor old poopy pants.
money-maker money-maker 22 minutes ago
https://twitter.com/TropicsStephen/status/1781600574049583544?t=B5whDwNll-2R5O5vvh4cbw&s=19
SPZI
Pastortec Pastortec 26 minutes ago
BAYER i recommend buy VOIS. The company that sell the stocks sell with them all its patents and one of them can influence with certain on your future sales.
VOIS
shermann7 shermann7 36 minutes ago
I personally think that Tulsi Gabbard is the Leading candidate to be Trumps VP candidate ... For whatever that is worth ...

Shermann
S-Boogie S-Boogie 47 minutes ago
"Delinquent SEC Reporting"... I guess nate has officially washed his hands of this ticker.
NHMD
Horseb4CarT Horseb4CarT 48 minutes ago
I used to drink one glass of red wine with dinner and had replaced that with nonalcoholic low calorie beer. Then my last lab results were shockingly different (bad) and I’m drinking water, coffee, and green and herbal teas and as little sugar as possible and very low carbs in general.
NWBO
kgromax kgromax 49 minutes ago
Excepted it shows Cytodyn was nowhere and has lied to its investors. What about that BLA data claimed publicly (PR!) by the CEO Nader to have been submitted to the FDA but that in fact was NOT submitted?

A corporate scam.
CYDY
Preciouslife1 Preciouslife1 49 minutes ago
https://www.facebook.com/share/r/VMyMPw4dsAAMef7V/?mibextid=6GsUZ4
janice shell janice shell 1 hour ago
This is SO SAD!!

https://twitter.com/CalltoActivism/status/1781758041609646286
janice shell janice shell 1 hour ago
This is SO SAD!!

https://twitter.com/CalltoActivism/status/1781758041609646286
satter satter 1 hour ago
I don't hold Trump for words taken out of context, or when it's a snippet and it's missing the complete video. If I do then point it out. You want to argue he did not say Bleach. I won't argue and say he said it. There is plenty to argue on what he did say. And that is a perfect example of you peopl
DJT
Investor2014 Investor2014 1 hour ago
That is correct.
I would suspect that many of the 1.7 million pages will never see the light of day
The vast majority of 'pages' of a regulatory submission consist of data items that may be part of various assessments done in the approval process, but unlikely that all is covered and u
AVXL
Wise Man Wise Man 1 hour ago
The link between unrealized losses and the conservatorship is clear.
FnF were placed in conservatorship pursuant to the FHEFSSA section 1367(a) APPOINTMENT OF THE AGENCY AS CONSERVATOR (which, by the way, was an amendment inserted by HERA in the FHEFSSA), according to the SPSPA:
https:
FNMA
newmedman newmedman 1 hour ago
I try really hard and I really like the kids. They always get the best of me but I try to teach them that there is a better life. I'm a sucker for the handicapped. I just want them to know that this world is a big place and there's room for all of us, no matter what our limitations
Investor2014 Investor2014 1 hour ago
The P2b/3 MRI brain region volumetric biomarker top level results Anavex have published so far are encouraging and I'm looking forward to more detail on that, the data overall and correlations between all the various measures, when presented or published hopefully soon'ish.

Meanwhile
AVXL
shermann7 shermann7 1 hour ago
From a Legal Standpoint, the Federal Government should be working with each state to exert their control over the prices ... States are protected by the 10th Amendment while the Federal Govt is subject to the U.S. Supreme Court. There is no constitutional Guarantee for the Federal Govt to do this.
Bull_Dolphin Bull_Dolphin 1 hour ago
Brandon pisses them all off, even Megan:

https://revolver.news/2024/04/latest-biden-radical-move-turned-megyn-kelly-red-hot-pissed-off-mama/
fuagf fuagf 1 hour ago
Att. conix: How Big Pharma is fighting Biden’s program to lower seniors’ drug costs

"[...]Now read the other part of the equation on Medicare Advantage plans. The big health insurance companies will not be getting paid as much, that is not cutting anything, except that annual big boo

Your Recent History

Delayed Upgrade Clock